Company
After The Stock Fell -1.28% Over The Week, Is Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Still A Buy?
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares stood at 0.99 million during the latest session, with the company’s beta value hitting 1.19. At the last check
